{"id":7779,"date":"2024-11-18T10:58:36","date_gmt":"2024-11-18T02:58:36","guid":{"rendered":"https:\/\/regask.com\/?p=7779"},"modified":"2024-11-21T17:44:39","modified_gmt":"2024-11-21T09:44:39","slug":"el-ministerio-de-salud-y-bienestar-de-japon-promueve-las-aprobaciones-de-medicamentos-de-marca-registrada","status":"publish","type":"post","link":"https:\/\/regask.com\/es\/japan-mhlw-promotes-rwd-pharma-approvals\/","title":{"rendered":"MHLW (Jap\u00f3n) fomenta el uso de datos del mundo real (RWD) para\u2026"},"content":{"rendered":"<p>El 7 de octubre de 2024, el Ministerio de Salud, Trabajo y Bienestar Social de Jap\u00f3n (MHLW) emiti\u00f3 una importante notificaci\u00f3n que fomenta el uso de Datos del Mundo Real (RWD) para respaldar modificaciones parciales en las aprobaciones de productos farmac\u00e9uticos. Esta actualizaci\u00f3n, destacada en un art\u00edculo de Pharma Japan, representa un avance estrat\u00e9gico hacia el uso de datos de registros de pacientes \u2014que abarcan perfiles de enfermedades, detalles espec\u00edficos del tratamiento y resultados de seguimiento\u2014 como una alternativa cre\u00edble a los ensayos cl\u00ednicos tradicionales para ciertos cambios regulatorios. La iniciativa subraya el compromiso del MHLW con el uso de evidencia del mundo real en las decisiones regulatorias, mejorando as\u00ed la innovaci\u00f3n en la atenci\u00f3n m\u00e9dica y la gesti\u00f3n del ciclo de vida de los productos farmac\u00e9uticos.<\/p>\n<p><strong>Puntos clave de la notificaci\u00f3n<\/strong><\/p>\n<p>La notificaci\u00f3n se dirige a las compa\u00f1\u00edas farmac\u00e9uticas que buscan modificaciones en las aprobaciones de productos que no requieren ensayos cl\u00ednicos a gran escala. Estos cambios pueden incluir ajustes en:<\/p>\n<ul>\n<li><strong>Indicaciones<\/strong>:Ampliar o especificar los usos terap\u00e9uticos.<\/li>\n<li><strong>Dosis<\/strong>:Modificaciones en las dosis recomendadas.<\/li>\n<li><strong>Otros aspectos clave<\/strong>:Varios cambios significativos, seg\u00fan lo definido por MHLW.<\/li>\n<\/ul>\n<p>RWD, que abarca datos de fuentes como registros m\u00e9dicos electr\u00f3nicos (EHRs), registros de enfermedades y productos, resultados informados por los pacientes y datos de entornos de uso dom\u00e9stico, brinda informaci\u00f3n valiosa de entornos cl\u00ednicos reales y ofrece un complemento pr\u00e1ctico a los ensayos cl\u00ednicos tradicionales.<\/p>\n<p><strong>Alcance y recomendaciones<\/strong><\/p>\n<p>Si bien las \u00e1reas terap\u00e9uticas o categor\u00edas de productos no est\u00e1n definidas espec\u00edficamente, la notificaci\u00f3n sugiere que la pol\u00edtica podr\u00eda aplicarse a una amplia gama de productos farmac\u00e9uticos y m\u00e9dicos. Se recomienda a las empresas que consideren RWD para su presentaci\u00f3n a las autoridades regulatorias que consulten con el MHLW en las primeras etapas del proceso para confirmar que sus datos cumplen con los est\u00e1ndares de calidad, relevancia y fiabilidad del MHLW.<\/p>\n<p><strong>Conclusi\u00f3n<\/strong><\/p>\n<p>Esta iniciativa del MHLW anima a las compa\u00f1\u00edas farmac\u00e9uticas japonesas a aprovechar la evidencia cient\u00edfica como un recurso regulatorio v\u00e1lido, promoviendo adaptaciones eficientes y basadas en datos en las aprobaciones de productos. A medida que Jap\u00f3n contin\u00faa adoptando la evidencia del mundo real en la atenci\u00f3n m\u00e9dica, este enfoque acelerar\u00e1... <a href=\"https:\/\/regask.com\/es\/registro-de-ingredientes-cosmeticos-en-japon\/\">v\u00eda reguladora<\/a> para tratamientos innovadores, garantizando el acceso oportuno a terapias mejoradas.<\/p>\n<hr \/>","protected":false},"excerpt":{"rendered":"<p>On October 7, 2024, Japan\u2019s Ministry of Health, Labor, and Welfare (MHLW) issued a significant notification encouraging the use of Real-World Data (RWD) to support partial modifications in pharmaceutical product approvals. This update, highlighted in an article by Pharma Japan, represents a strategic move towards utilizing patient registry data\u2014covering disease profiles, treatment specifics, and follow-up&#8230;<\/p>","protected":false},"author":43,"featured_media":7847,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[35,519],"tags":[387,496],"class_list":["post-7779","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-pharma-biotech-latest-insights","category-japan-regulations","tag-real-word-evidence-rwe","tag-market-authorization-regs"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v27.6 (Yoast SEO v27.6) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Japan MHLW Promotes RWD for Pharma Approvals | RegASK<\/title>\n<meta name=\"description\" content=\"Japan\u2019s MHLW encourages use of real-world data for pharma approval, boosting innovation. Read more at RegASK.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/regask.com\/es\/el-ministerio-de-salud-y-bienestar-de-japon-promueve-las-aprobaciones-de-medicamentos-de-marca-registrada\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"MHLW (Japan) Encourages Use of Real-World Data (RWD) for Modifications in Pharmaceutical Approvals\" \/>\n<meta property=\"og:description\" content=\"Japan\u2019s MHLW encourages use of real-world data for pharma approval, boosting innovation. Read more at RegASK.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/regask.com\/es\/el-ministerio-de-salud-y-bienestar-de-japon-promueve-las-aprobaciones-de-medicamentos-de-marca-registrada\/\" \/>\n<meta property=\"og:site_name\" content=\"RegASK\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/RegASKRegulatoryAffairs\/\" \/>\n<meta property=\"article:published_time\" content=\"2024-11-18T02:58:36+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-11-21T09:44:39+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/regask.com\/wp-content\/uploads\/2024\/11\/mhlw-japan-encourages-use-real-world-data-rwd-modifications-pharmaceutical-approvals.png\" \/>\n\t<meta property=\"og:image:width\" content=\"800\" \/>\n\t<meta property=\"og:image:height\" content=\"600\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Reva Ananda\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@ASKRegASK\" \/>\n<meta name=\"twitter:site\" content=\"@ASKRegASK\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Reva Ananda\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/regask.com\\\/japan-mhlw-promotes-rwd-pharma-approvals\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/regask.com\\\/japan-mhlw-promotes-rwd-pharma-approvals\\\/\"},\"author\":{\"name\":\"Reva Ananda\",\"@id\":\"https:\\\/\\\/regask.com\\\/#\\\/schema\\\/person\\\/4023a3aab44f61a84d06ca8abfcbe926\"},\"headline\":\"MHLW (Japan) Encourages Use of Real-World Data (RWD) fo&hellip;\",\"datePublished\":\"2024-11-18T02:58:36+00:00\",\"dateModified\":\"2024-11-21T09:44:39+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/regask.com\\\/japan-mhlw-promotes-rwd-pharma-approvals\\\/\"},\"wordCount\":299,\"publisher\":{\"@id\":\"https:\\\/\\\/regask.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/regask.com\\\/japan-mhlw-promotes-rwd-pharma-approvals\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/mhlw-japan-encourages-use-real-world-data-rwd-modifications-pharmaceutical-approvals.png\",\"keywords\":[\"Real-Word-Evidence (RWE)\",\"Market authorization regs\"],\"articleSection\":[\"Pharma and Biotech\",\"Japan\"],\"inLanguage\":\"es\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/regask.com\\\/japan-mhlw-promotes-rwd-pharma-approvals\\\/\",\"url\":\"https:\\\/\\\/regask.com\\\/japan-mhlw-promotes-rwd-pharma-approvals\\\/\",\"name\":\"Japan MHLW Promotes RWD for Pharma Approvals | RegASK\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/regask.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/regask.com\\\/japan-mhlw-promotes-rwd-pharma-approvals\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/regask.com\\\/japan-mhlw-promotes-rwd-pharma-approvals\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/mhlw-japan-encourages-use-real-world-data-rwd-modifications-pharmaceutical-approvals.png\",\"datePublished\":\"2024-11-18T02:58:36+00:00\",\"dateModified\":\"2024-11-21T09:44:39+00:00\",\"description\":\"Japan\u2019s MHLW encourages use of real-world data for pharma approval, boosting innovation. Read more at RegASK.\",\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/regask.com\\\/japan-mhlw-promotes-rwd-pharma-approvals\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/regask.com\\\/japan-mhlw-promotes-rwd-pharma-approvals\\\/#primaryimage\",\"url\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/mhlw-japan-encourages-use-real-world-data-rwd-modifications-pharmaceutical-approvals.png\",\"contentUrl\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/mhlw-japan-encourages-use-real-world-data-rwd-modifications-pharmaceutical-approvals.png\",\"width\":800,\"height\":600,\"caption\":\"Mhlw Japan Encourages Use Real World Data Rwd Modifications Pharmaceutical Approvals\"},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/regask.com\\\/#website\",\"url\":\"https:\\\/\\\/regask.com\\\/\",\"name\":\"RegASK\",\"description\":\"Empowering Smarter Regulatory Decisions\",\"publisher\":{\"@id\":\"https:\\\/\\\/regask.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/regask.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/regask.com\\\/#organization\",\"name\":\"RegASK\",\"url\":\"https:\\\/\\\/regask.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/regask.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2024\\\/10\\\/RegASK-Logo-Dark-Round.png\",\"contentUrl\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2024\\\/10\\\/RegASK-Logo-Dark-Round.png\",\"width\":401,\"height\":401,\"caption\":\"RegASK\"},\"image\":{\"@id\":\"https:\\\/\\\/regask.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/RegASKRegulatoryAffairs\\\/\",\"https:\\\/\\\/x.com\\\/ASKRegASK\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/RegASK\\\/\",\"https:\\\/\\\/www.youtube.com\\\/@RegASK\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/regask.com\\\/#\\\/schema\\\/person\\\/4023a3aab44f61a84d06ca8abfcbe926\",\"name\":\"Reva Ananda\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"El Ministerio de Salud, Trabajo y Bienestar de Jap\u00f3n promueve la autorizaci\u00f3n de medicamentos (RWD) para la aprobaci\u00f3n de medicamentos | RegASK","description":"El Ministerio de Salud, Trabajo y Bienestar Social de Jap\u00f3n fomenta el uso de datos reales para la aprobaci\u00f3n de medicamentos, impulsando as\u00ed la innovaci\u00f3n. Lea m\u00e1s en RegASK.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/regask.com\/es\/el-ministerio-de-salud-y-bienestar-de-japon-promueve-las-aprobaciones-de-medicamentos-de-marca-registrada\/","og_locale":"es_ES","og_type":"article","og_title":"MHLW (Japan) Encourages Use of Real-World Data (RWD) for Modifications in Pharmaceutical Approvals","og_description":"Japan\u2019s MHLW encourages use of real-world data for pharma approval, boosting innovation. Read more at RegASK.","og_url":"https:\/\/regask.com\/es\/el-ministerio-de-salud-y-bienestar-de-japon-promueve-las-aprobaciones-de-medicamentos-de-marca-registrada\/","og_site_name":"RegASK","article_publisher":"https:\/\/www.facebook.com\/RegASKRegulatoryAffairs\/","article_published_time":"2024-11-18T02:58:36+00:00","article_modified_time":"2024-11-21T09:44:39+00:00","og_image":[{"width":800,"height":600,"url":"https:\/\/regask.com\/wp-content\/uploads\/2024\/11\/mhlw-japan-encourages-use-real-world-data-rwd-modifications-pharmaceutical-approvals.png","type":"image\/png"}],"author":"Reva Ananda","twitter_card":"summary_large_image","twitter_creator":"@ASKRegASK","twitter_site":"@ASKRegASK","twitter_misc":{"Written by":"Reva Ananda","Est. reading time":"2 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/regask.com\/japan-mhlw-promotes-rwd-pharma-approvals\/#article","isPartOf":{"@id":"https:\/\/regask.com\/japan-mhlw-promotes-rwd-pharma-approvals\/"},"author":{"name":"Reva Ananda","@id":"https:\/\/regask.com\/#\/schema\/person\/4023a3aab44f61a84d06ca8abfcbe926"},"headline":"MHLW (Japan) Encourages Use of Real-World Data (RWD) fo&hellip;","datePublished":"2024-11-18T02:58:36+00:00","dateModified":"2024-11-21T09:44:39+00:00","mainEntityOfPage":{"@id":"https:\/\/regask.com\/japan-mhlw-promotes-rwd-pharma-approvals\/"},"wordCount":299,"publisher":{"@id":"https:\/\/regask.com\/#organization"},"image":{"@id":"https:\/\/regask.com\/japan-mhlw-promotes-rwd-pharma-approvals\/#primaryimage"},"thumbnailUrl":"https:\/\/regask.com\/wp-content\/uploads\/2024\/11\/mhlw-japan-encourages-use-real-world-data-rwd-modifications-pharmaceutical-approvals.png","keywords":["Real-Word-Evidence (RWE)","Market authorization regs"],"articleSection":["Pharma and Biotech","Japan"],"inLanguage":"es"},{"@type":"WebPage","@id":"https:\/\/regask.com\/japan-mhlw-promotes-rwd-pharma-approvals\/","url":"https:\/\/regask.com\/japan-mhlw-promotes-rwd-pharma-approvals\/","name":"El Ministerio de Salud, Trabajo y Bienestar de Jap\u00f3n promueve la autorizaci\u00f3n de medicamentos (RWD) para la aprobaci\u00f3n de medicamentos | RegASK","isPartOf":{"@id":"https:\/\/regask.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/regask.com\/japan-mhlw-promotes-rwd-pharma-approvals\/#primaryimage"},"image":{"@id":"https:\/\/regask.com\/japan-mhlw-promotes-rwd-pharma-approvals\/#primaryimage"},"thumbnailUrl":"https:\/\/regask.com\/wp-content\/uploads\/2024\/11\/mhlw-japan-encourages-use-real-world-data-rwd-modifications-pharmaceutical-approvals.png","datePublished":"2024-11-18T02:58:36+00:00","dateModified":"2024-11-21T09:44:39+00:00","description":"El Ministerio de Salud, Trabajo y Bienestar Social de Jap\u00f3n fomenta el uso de datos reales para la aprobaci\u00f3n de medicamentos, impulsando as\u00ed la innovaci\u00f3n. Lea m\u00e1s en RegASK.","inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/regask.com\/japan-mhlw-promotes-rwd-pharma-approvals\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/regask.com\/japan-mhlw-promotes-rwd-pharma-approvals\/#primaryimage","url":"https:\/\/regask.com\/wp-content\/uploads\/2024\/11\/mhlw-japan-encourages-use-real-world-data-rwd-modifications-pharmaceutical-approvals.png","contentUrl":"https:\/\/regask.com\/wp-content\/uploads\/2024\/11\/mhlw-japan-encourages-use-real-world-data-rwd-modifications-pharmaceutical-approvals.png","width":800,"height":600,"caption":"Mhlw Japan Encourages Use Real World Data Rwd Modifications Pharmaceutical Approvals"},{"@type":"WebSite","@id":"https:\/\/regask.com\/#website","url":"https:\/\/regask.com\/","name":"RegASK","description":"Habilitando decisiones regulatorias m\u00e1s inteligentes","publisher":{"@id":"https:\/\/regask.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/regask.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/regask.com\/#organization","name":"RegASK","url":"https:\/\/regask.com\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/regask.com\/#\/schema\/logo\/image\/","url":"https:\/\/regask.com\/wp-content\/uploads\/2024\/10\/RegASK-Logo-Dark-Round.png","contentUrl":"https:\/\/regask.com\/wp-content\/uploads\/2024\/10\/RegASK-Logo-Dark-Round.png","width":401,"height":401,"caption":"RegASK"},"image":{"@id":"https:\/\/regask.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/RegASKRegulatoryAffairs\/","https:\/\/x.com\/ASKRegASK","https:\/\/www.linkedin.com\/company\/RegASK\/","https:\/\/www.youtube.com\/@RegASK"]},{"@type":"Person","@id":"https:\/\/regask.com\/#\/schema\/person\/4023a3aab44f61a84d06ca8abfcbe926","name":"Reva Ananda"}]}},"_links":{"self":[{"href":"https:\/\/regask.com\/es\/wp-json\/wp\/v2\/posts\/7779","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/regask.com\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/regask.com\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/regask.com\/es\/wp-json\/wp\/v2\/users\/43"}],"replies":[{"embeddable":true,"href":"https:\/\/regask.com\/es\/wp-json\/wp\/v2\/comments?post=7779"}],"version-history":[{"count":0,"href":"https:\/\/regask.com\/es\/wp-json\/wp\/v2\/posts\/7779\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/regask.com\/es\/wp-json\/wp\/v2\/media\/7847"}],"wp:attachment":[{"href":"https:\/\/regask.com\/es\/wp-json\/wp\/v2\/media?parent=7779"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/regask.com\/es\/wp-json\/wp\/v2\/categories?post=7779"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/regask.com\/es\/wp-json\/wp\/v2\/tags?post=7779"}],"curies":[{"name":"Gracias","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}